MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
54.76%
Quick Ratio
54.76%
Debt to Asset Ratio
423.34%
Unit: Thousand (K) dollars
Assets Breakdown
Other long-term assets
Restricted cash
Prepaid expenses
Others
Liabilities Breakdown
Accumulated deficit
Common shares, no par value, unl...
Additional paid-in capital
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
-
935
613
553
Restricted cash and restricted cash equivalents
-
3,161
1,024
-
Cash
1,020
-
-
-
Restricted cash
3,085
-
-
-
Prepaid expenses
1,845
2,209
2,013
1,857
Restricted cash equivalents, current
-
-
-
745
Other current assets
205
141
127
116
Total current assets
6,155
6,446
3,777
3,271
Property, plant and equipment, gross-Computer Equipment
-
5
-
-
Accumulated depreciation-Computer Equipment
-
5
-
-
Property, plant and equipment, gross-Software And Software Development Costs
-
218
-
-
Accumulated depreciation-Software And Software Development Costs
-
218
-
-
Property, plant and equipment, gross-Furniture And Fixtures
-
118
-
-
Accumulated depreciation-Furniture And Fixtures
-
118
-
-
Property, plant and equipment, gross-Leasehold Improvements
-
171
-
-
Accumulated depreciation-Leasehold Improvements
-
167
-
-
Property and equipment, net
2
4
8
19
Right-of-use assets, operating leases
71
175
277
377
Other long-term assets
4,495
3,387
2,279
1,924
Total non-current assets
4,568
3,566
2,564
2,320
Total assets
10,723
10,012
6,341
5,591
Accounts payable
3,810
2,911
1,456
2,879
Accrued liabilities
7,349
6,202
4,804
5,414
Current portion of lease liability, operating leases
80
193
305
413
Interest on related party loan payable
-
-
514
294
Total current liabilities
11,239
9,306
7,079
9,000
Lease liability, operating leases
-
0
0
0
Loan payable to related party
32,870
27,018
18,712
10,962
Interest on related party loan payable
1,286
855
-
-
Total non-current liabilities
34,156
27,873
18,712
10,962
Total liabilities
45,395
37,179
25,791
19,962
Common shares, no par value, unlimited authorized shares, 2,552,429 issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
459,771
459,771
459,771
459,771
Additional paid-in capital
83,942
83,813
83,771
83,727
Accumulated other comprehensive loss
-4,316
-4,316
-4,316
-4,316
Accumulated deficit
-574,069
-566,435
-558,676
-553,553
Total shareholders' deficit
-34,672
-27,167
-19,450
-14,371
Total liabilities and shareholders' deficit
10,723
10,012
6,341
5,591
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Restricted cash
$3,085K
Prepaid expenses
$1,845K
Cash
$1,020K
Other current assets
$205K
Other long-term
assets
$4,495K
Right-of-use assets,
operating leases
$71K
Property and equipment,
net
$2K
Total current assets
$6,155K
Total non-current
assets
$4,568K
Total assets
$10,723K
Accumulated deficit
-$574,069K
Accumulated other
comprehensive loss
-$4,316K
Total liabilities and
shareholders' deficit
$10,723K
Total shareholders'
deficit
-$34,672K
Common shares, no par
value, unlimited...
$459,771K
Additional paid-in capital
$83,942K
Total liabilities
$45,395K
Total non-current
liabilities
$34,156K
Total current
liabilities
$11,239K
Loan payable to
related party
$32,870K
Interest on related party
loan payable
$1,286K
Accrued liabilities
$7,349K
Accounts payable
$3,810K
Current portion of lease
liability, operating...
$80K
Buy us a coffee
Aptose Biosciences Inc. (APTOF)
Aptose Biosciences Inc. (APTOF)